Insight, analysis & opinion from Joe Paduda

< Back to Home


Flu season and Tamiflu – which one’s more hyped?

It’s full-on panic mode; flu season is upon us, the media’s in a frenzy, and the world is coming to an end.  If you didn’t get your shot, you’re going to be in serious trouble, laid up for weeks with a nasty case of the horribles if not stuck in a hospital ER with tubes dangling from your appendages.

To listen/watch the media, you’d think the Mayans were right about the end of the world, if not precise with the timing or cause of earth’s demise. Then again, this is what (much of) the media does – generate eyeballs/ears by getting us all excited about something or other.  Now that the most recent fiscal crisis is a distant memory, there’s got to be something to get us riled up – so flu it is.

Unfortunately the sensationalism isn’t limited to the illness itself; the enthusiasm for Tamiflu, the equivalent of the mining-after pill for flu sufferers, is similarly hyped.

Through a combination of carefully-orchestrated clinical trials, precisely-written journal articles, and professionally-managed media placement, the makers of Tamiflu have been able to convince many of the drug’s powerful ability to moderate the effects and shorten the duration of the illness. Sounds like a no-brainer, except…

Except the reality is nowhere near as encouraging.  Turns out Tamiflu actually only shortens duration by a day or so, and while it can moderate the worst of the symptoms, isn’t going to get you up and going in no time.  Here’s what the Cochrane Collaboration, perhaps the world’s leading analysts of medical research and intervention concluded after reviewing the research behind Tamiflu:

1. The manufacturer of the drug sponsored all the trials and the reviewers found evidence of publication and reporting biases.

2. The studies did not show that Tamiflu (oseltamivir) reduced the risk of hospitalization.

3. The studies were inadequate to determine the effect of Tamiflu (oseltamivir) on complications.

4. The studies were inadequate to determine if Tamiflu (oseltamivir)  reduced transmission of the virus.

5. The use of Tamiflu (oseltamivir) did reduce the duration of symptoms by about a day.

I bring this to your attention, dear reader, not to scare you even more, but rather to encourage you to learn more about medical miracles/drugs/treatments before signing up.  If you don’t, you may well find yourself poorer, just as sick, and perhaps with a few side effects you hadn’t counted on.

Thanks to Gary Schwitzer at Health News Review for the tip; his blog is a must-read for those seeking the real story behind the mass media’s health hype of the moment.

6 thoughts on “Flu season and Tamiflu – which one’s more hyped?”

  1. How interesting. Many hospitals mandate that all employees get the flu shot as a condition of employment!

  2. The media hypes everything. Nothing is interesting enough as is. They take dull news and try to make it something exciting to talk about. The flu isn’t any worse this year, but there is money to be made off of the hype.

Comments are closed.

Joe Paduda is the principal of Health Strategy Associates



A national consulting firm specializing in managed care for workers’ compensation, group health and auto, and health care cost containment. We serve insurers, employers and health care providers.



© Joe Paduda 2024. We encourage links to any material on this page. Fair use excerpts of material written by Joe Paduda may be used with attribution to Joe Paduda, Managed Care Matters.

Note: Some material on this page may be excerpted from other sources. In such cases, copyright is retained by the respective authors of those sources.